Verrica Pharmaceuticals Inc (VRCA) reports strong YCANTH revenue and strategic advancements, but faces increased losses and ...

Insects can be deadly, causing physical harm, spreading diseases, and ruining crops. Species like mosquitoes, assassin ...

Company significantly reduces cost structure with a realigned sales, marketing and operational infrastructure - Sales and ...

About YCANTH® (VP-102) YCANTH® is a proprietary drug-device combination product that contains a GMP-controlled formulation of cantharidin delivered via a single-use applicator that allows for ...

Competition remains a concern for Verrica, particularly from residual compound cantharidin in the market. The presence of these competing products could potentially limit YCANTH's market share and ...

Company significantly reduces cost structure with a realigned sales, marketing and operational infrastructure - Sales and marketing efforts to focus on pediatricians and expand access beyond dermatolo ...